[Home ] [Archive]    
:: Main :: About :: Current Issue :: Archive :: Search :: Contact ::
Main Menu
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Contact us::
Site Facilities::
Medical Journalism::
Search in website

Advanced Search

:: Volume 6, Issue 2 (5-2012) ::
Iran J Virol 2012, 6(2): 1-7 Back to browse issues page
Partial Quality Control of Inactivated Split Human Influenza Vaccine 2008-9
SF Mousavi , M Tavassoti-Kheiri , M Taghizadeh , F Fotouhi , B Heydarchi , M Tabatabaiean , A Torabi , SM Hosseini *
Department of Microbiology, Faculty of Biological Sciences, Shahid-Beheshti University, Tehran, Iran
Abstract:   (5092 Views)
Background and Aims: Influenza vaccination is one of the best way to prevent and control influenza worldwide. It is manufactured by WHO-licensed companies based on the WHO expertise committee annually. The aim of this study was partial quality control of the commercial human influenza vaccine 2008-9 and its matching with the circulating strains. Materials and Methods: The trivalent imported vaccine was cultured in bacterial and fungal media, injected to the mice and inoculated into the allantoic cavity of Embryonated Chicken Eggs (ECEs). Hemagglutination-Inhibition (HI) assay was carried out on pre and post vaccination serum samples. The bacterial endotoxin was assessed by LAL assay. The Hemagglutinin (HA) content of the vaccine was measured using SRID. Heterogenecity of the circulating influenza strains during 2008-9 seasons in Tehran in comparison to the vaccine strains was determined. Results: No bacterial contamination and no occurrence of mortality and morbidity in animal was observed. The mean fold increase of HI antibody titer in subjects without previous vaccination for H1N1, H3N2 and B strains were 6.7, 3.3 and 1.8 respectively, while in subjects with previous vaccination were 4, 1.6 and 1.1 for same strains. Amino acid variation was found in Tehran H1N1 isolates but the H3N2 isolates showed higher genetic resemblance to the 2008-9 vaccine strain. Conclusion: The sterility, safety, and efficacy of the vaccine were approved and there was some variation in A/H1N1 but not in A/H3N2 isolates in comparison with the vaccine strain.
Keywords: Human influenza vaccine, Phylogenetic Analysis, Hemagglutination-Inhibition (HI)
Full-Text [PDF 273 kb]   (1067 Downloads)    
Type of Study: Original article | Subject: General
Received: 2014/11/7 | Accepted: 2014/11/7 | Published: 2014/11/7
Add your comments about this article
Your username or Email:


XML     Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Mousavi S, Tavassoti-Kheiri M, Taghizadeh M, Fotouhi F, Heydarchi B, Tabatabaiean M, et al . Partial Quality Control of Inactivated Split Human Influenza Vaccine 2008-9. Iran J Virol 2012; 6 (2) :1-7
URL: http://journal.isv.org.ir/article-1-89-en.html

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 6, Issue 2 (5-2012) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 39 queries by YEKTAWEB 4652